TSE:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis C$5.28 -0.27 (-4.86%) As of 01/31/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades About Aurora Cannabis Stock (TSE:ACB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aurora Cannabis alerts:Sign Up Key Stats Today's RangeC$5.28▼C$5.6150-Day RangeC$5.28▼C$6.8052-Week RangeC$3.84▼C$12.85Volume269,788 shsAverage Volume324,437 shsMarket CapitalizationC$288.60 millionP/E RatioN/ADividend YieldN/APrice TargetC$5.85Consensus RatingModerate Buy Company OverviewAurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.Read More… Aurora Cannabis Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks11th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingAurora Cannabis has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageAurora Cannabis has only been the subject of 1 research reports in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -8.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -8.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ACB. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ACB. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Aurora Cannabis this week, compared to 1 article on an average week.Search Interest13 people have searched for ACB on MarketBeat in the last 30 days. This is an increase of 63% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 13.38% of the stock of Aurora Cannabis is held by institutions.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address ACB Stock News HeadlinesAurora Cannabis announces corporate updateJanuary 24, 2025 | msn.comAurora Cannabis launches first domestic brand in GermanyJanuary 23, 2025 | msn.comHow 10 Minutes a Week Delivered 96.8% Accuracy for 9 YearsI've just interviewed a private millionaire who uncovered some strange movements in the market...February 1, 2025 | Investing Daily (Ad)Aurora Cannabis launches first German-cultivated medical cannabis productJanuary 23, 2025 | markets.businessinsider.comAurora Cannabis (ACB) Receives a Hold from ATB Capital MarketsDecember 18, 2024 | markets.businessinsider.comAurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For VeteransNovember 26, 2024 | benzinga.comAurora Cannabis Inc. (NASDAQ:ACB) Q2 2025 Earnings Call TranscriptNovember 8, 2024 | msn.comAurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?November 7, 2024 | benzinga.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at C$6.11 at the start of the year. Since then, ACB stock has decreased by 13.6% and is now trading at C$5.28. View the best growth stocks for 2025 here. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (TSE:ACB) posted its quarterly earnings results on Wednesday, November, 6th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.35. Aurora Cannabis had a negative trailing twelve-month return on equity of 6.13% and a negative net margin of 11.53%. How do I buy shares of Aurora Cannabis? Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Meta Platforms (META), NVIDIA (NVDA), Organigram (OGI) and Aurora Cannabis (ACBFF). Company Calendar Last Earnings11/06/2024Today2/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:ACB CUSIPN/A CIKN/A Webauroramj.com Phone+1-604-3625207FaxN/AEmployees1,073Year FoundedN/APrice Target and Rating Average Stock Price TargetC$5.85 High Stock Price TargetC$9.00 Low Stock Price TargetC$0.80 Potential Upside/Downside+10.8%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-30,320,000.00 Net Margins-11.53% Pretax MarginN/A Return on Equity-6.13% Return on Assets-1.87% Debt Debt-to-Equity Ratio16.95 Current Ratio3.76 Quick Ratio2.48 Sales & Book Value Annual SalesC$278.98 million Price / Sales1.03 Cash FlowC$4.24 per share Price / Cash Flow1.25 Book ValueC$10.28 per share Price / Book0.51Miscellaneous Outstanding Shares54,660,000Free FloatN/AMarket CapC$288.60 million OptionableNot Optionable Beta2.71 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (TSE:ACB) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.